Meribank Biotech Cash Flow Statement

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	-81.47	-94.71	-125.35	-102.13	-99.19
Depreciation & Amortization	155.41	83.22	34.28	32.16	29.47
Other Amortization	-	0.81	2.25	-	-
Loss (Gain) From Sale of Assets	-	-0.01	-0.07	-	-
Asset Writedown & Restructuring Costs	8.26	-	5.67	-	-
Loss (Gain) From Sale of Investments	8.38	-2.72	-	-5.79	-0.18
Loss (Gain) on Equity Investments	3.63	11.93	5.41	5.42	4.51
Stock-Based Compensation	7.89	2.51	1.17	0.02	0.34
Provision & Write-off of Bad Debts	5.46	1.23	3.84	-0.59	5.28
Other Operating Activities	-8.01	-7.28	-4.14	-1.45	-0.37
Change in Accounts Receivable	-33.03	-29.99	17.6	-6.25	-14.2
Change in Inventory	4.82	-4.34	1.54	-4.84	-0.67
Change in Accounts Payable	-6.16	1.85	3.29	2.3	-0.24
Change in Unearned Revenue	9.59	22.83	12.22	10.52	33.6
Change in Other Net Operating Assets	14.67	-23.42	12.58	29.31	18.66
Operating Cash Flow	89.45	-38.09	-29.7	-41.33	-23
Capital Expenditures	-3.84	-248.61	-5.8	-4.15	-7.21
Sale of Property, Plant & Equipment	-	0.01	-	-	-
Cash Acquisitions	-11	15.44	-4.42	-1.27	-
Sale (Purchase) of Intangibles	-1.05	-95.58	-0.88	-0.09	-0.31
Investment in Securities	-131.9	-14.49	83.62	-23.03	-75.83
Other Investing Activities	-22.3	-19.23	-24.37	-16.46	-34.72
Investing Cash Flow	-170.08	-362.46	48.15	-45.01	-118.07
Long-Term Debt Issued	-	175	-	-	-
Long-Term Debt Repaid	-77.95	-38.76	-22.78	-20.34	-17.98
Net Debt Issued (Repaid)	-77.95	136.24	-22.78	-20.34	-17.98
Issuance of Common Stock	120	-	311.6	-	300
Other Financing Activities	-28.34	29.94	7.03	-0.32	-0.2
Financing Cash Flow	13.71	166.17	295.85	-20.66	281.82
Foreign Exchange Rate Adjustments	-0.73	-	-	-	-
Net Cash Flow	-67.65	-234.37	314.3	-106.99	140.76
Free Cash Flow	85.62	-286.7	-35.5	-45.48	-30.2
Free Cash Flow Margin	18.15%	-78.24%	-15.15%	-25.25%	-18.52%
Free Cash Flow Per Share	0.94	-3.60	-0.56	-0.72	-0.50
Cash Interest Paid	-	10.7	0.85	0.99	1.13
Cash Income Tax Paid	-	0.03	-	-	-
Levered Free Cash Flow	56.7	-330.4	-11.46	-43.73	-55.04
Unlevered Free Cash Flow	71.14	-323.71	-10.93	-43.12	-54.33
Change in Working Capital	-10.1	-33.06	47.23	31.04	37.15

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.